EUCTR2005-001486-33-DE进行中（未招募）1 期
Efficacy and safety of levetiracetam in the inpatient treatment of alcohol withdrawal syndrome[Sicherheit und Wirksamkeit von Levetiracetam (Keppra) für die Behandlung des stationären Alkoholentzugsyndroms] - Keppra 1
Charité Campus Mitte, Klinik für Psychiatrie und Psychotherapie0 个研究点目标入组 120 人开始时间: 2005年6月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Ages eligible for study: 18-65 years.
- •Meets criteria for alcohol dependence according to DSM-IV/ICD-10
- •Known withdrawal symptoms in the past in case of discontinuation of alcohol consumption
- •Hospital admission for alcohol detoxification
- •Able to provide a written informed consent.
- •Able to follow verbal and written instructions (incl. a sufficient knowledge of German language).
- •Must be medically acceptable for study treatment. No past or present physical disorder that is likely to deteriorate during participation. No ECG abnormality which would likely worsen during participation and no clinical laboratory abnormality that would also suggest deterioration during treatment.
- •have a negative urine drug screen for benzodiazepines or heroine or methadone
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Current diagnosis of any other substance dependence syndrome other than alcohol dependence (excluding nicotine and caffeine dependence).
- •History of idiopathic epilepsy.
- •Patient with any current clinically significant psychiatric disorder (acute suiciality) or developmen-tal disorder (including organic mental disorder), like psychotic disorders.
- •Patients with the following complications of alcoholism (lifetime): acute delirium tremens, hallucinatory alcoholic state, Korsakoff`s syndrome, Wernicke encephalopathy, decompensed liver cirrhosis (Child B, C), suspected cirrhosis with the following clinical symptoms detected at clinical exam: signs of portal hypertension and signs of hepato-cellular failure, thrombozytopenia.
- •Subjects with known sensitivity of previous adverse reaction to levetiracetam
- •Contra-indication (hypersensitivity to levetiracetam or pyrrolidon derivatives) or known non-response to levetiracetam.
- •History of severe GI disease which might render absorption of the medication difficult or produce medical instability of the patient which would include active peptic ulcer disease, ulcerative colitis, regional colitis, or evidence by history or physical exam of GI bleeding.
- •Patients with any clinically significant acute or chronic progressive neurological, gastrointestinal, cardiovascular, hepatic, renal, haematological, endocrine, derma-tological or respiratory disease, such as diabetes, severe infection, acute alcoholic hepatitis, or any other medical condition with significant worsening of the clinical situation of the patient that might interfere with the evaluation of study medica-tion.
- •Female patients pregnant, breast-feeding or of child bearing age and not protected by effective contraceptive such as implants, injectables, combined oral contracep-tives, some IUDS, sexual abstinence, sterilization or vasectomised partner.
- •actually continous use of pharmacological agents that are known to lower the seizure threshold or augment or decrease the alcohol withdrawal syndrome.
- •Subjects with known sensitivity of previous adverse reaction to diazepam or clo-nidine
- •Contra-indication or known non-response to diazepam or clonidine
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety of Levetiracetam treatment in patients suffering from Restless Legs SyndromeEficacia y seguridad de un tratamiento con levetiracetam en pacientes con síndrome idiopático de piernas inquietasRestless legs syndrome (RLS)EUCTR2005-001516-41-ESClínica Plató Fundació Privada12
已完成
不适用
Study on efficacy and safety of levetiracetam administration by nasogastric tube in patients with convulsive status epilepticusConvulsive status epilepticusJPRN-UMIN000010552Department of Emergency and Critical Care Medicine, Wakayama Medical University20
招募中
2 期
The effect of levetiracetam and phenobarbital on the control of neonatal seizuresIRCT20160523028008N23Hamedan University of Medical Sciences40
进行中（未招募）
不适用
Prospective trial of intravenous levetiracetam in patients with primary brain tumors and at least one symptomatic seizure who undergo biopsy or cytoreductive surgery. - HELLO-StudyMedDRA version: 9.1Level: LLTClassification code 10015037Term: EpilepsyEpilepsyEUCTR2007-005063-96-DEniversity Hospital Tübingen
已完成
2 期
Efficacy and safety of levetiracetam therapy for early postoperative seizures following brain tumor surgeryearly postoperative seizures following brain tumor surgeryJPRN-UMIN000009984Department of Neurosurgery, Shiga University of Medical Science50